News

Studies have shown that women suffer a higher risk of developing dementia than men. Now, a study reports that this gender difference seems to be mirrored by molecular changes in brain proteins, raising prospects of identifying better treatments for both men and women. “The number of dementia patients is projected to triple…

In September 2015, a study published in the journal Nature significantly stirred the scientific community and made people around the world understandably alarmed. The research suggested that Alzheimer’s disease might be transmittable through injections of the disease-driving protein amyloid-β. Researchers all over the world now race to further investigate these…

Progressive supranuclear palsy is a brain disease that causes difficulty with walking, balance, and eye movements. The nonprofit CurePSP is dedicated to finding treatments and a cure for the disease, but its mission also extends beyond PSP. By initiating clinical trials to study PSP as well as head injury due to concussion,…

Two previously failed drug candidates, Eli Lilly’s Solanezumab and Roche’s Gantenerumab, are again under clinical study for Alzheimer’s disease. Both drugs are immunotherapies targeting amyloid-beta in the brain, a target that researchers — including Dr. Michael Geschwind, who spoke with Alzheimer’s News Today — think has the potential to revolutionize…

During the American Chemical Society annual meeting, leading international researchers shared promising findings of 24 studies that looked at the beneficial effects of natural products on brain health and on the prevention of Alzheimer’s and other neurodegenerative diseases. For the first time, the beneficial effects of pure maple syrup…

The National Institute on Aging (NIA) and the National Institute of Neurological Disorders and Stroke (NINDS), both part of the National Institutes of Health (NIH), have launched the Molecular Mechanisms of the Vascular Etiology of Alzheimer’s Disease (M²OVE-AD) Consortium to better understand how the body’s vascular system, its network of large and…

Blueberries, a “super fruit” known to decrease the risk of cancer and heart disease, may also be of benefit against Alzheimer’s disease, according to findings recently presented at the 251st National Meeting & Exposition of the American Chemical Society (ACS). Blueberries are loaded with antioxidants, which, according to researchers, could…

CurePSP is a Maryland-based nonprofit organization that focuses on neurodegenerative diseases that strike when people are in their 50s to 70s, including Alzheimer’s disease. PSP stands for progressive supranuclear palsy, which is a neurodegenerative disorder that impacts movement, walking, speech, balance, mood, vision, behavior, and cognition. Like Alzheimer’s, PSP is characterized by…

European scientists have demonstrated that a nutritional drink, Fortasyn Connect, does not benefit broad cognitive function to the degree expected, but it can help to conserve brain tissue and memory in early, or prodromal, Alzheimer’s disease patients. The clinical trial is part of the LipiDiDiet project, a large European study exploring the therapeutic and…

An editorial by a large number of senior Alzheimer’s researchers urges the scientific community to take a serious look at evidence pointing to the contribution of microbes in the development of Alzheimer’s disease – and calling for more clinical research. Published online in the Journal of Alzheimer’s Disease by…